Pregnancy Clinical Trial
Official title:
Modifying Maternal Sleep Position in the Third Trimester of Pregnancy With Positional Therapy: A Randomized Pilot Trial
Back and right-sided sleeping position in pregnant women has recently emerged as a potential
risk factor for low birthweight (LBW) and stillbirth (SB) in the medical literature. Assuming
that sleep position in pregnant women is modifiable, the same literature has indicated that
this risk factor is modifiable; however, there is no evidence that this risk factor is truly
modifiable.
The proposed link between back and right-sided sleeping position in a pregnant woman and LBW
and SB of her baby is multifactorial; however, it ultimately implicates the woman's body
position in causing compression of one of the large veins that brings blood back to her
heart. This compression, along with other factors relating to the woman, her placenta, and
her developing fetus, may result in decreased blood flow (nutrition and oxygen) to her
developing baby, which, depending on the extent and duration, could result in LBW or SB of
her baby. If the back sleeping position during pregnancy has a causative role in LBW and
subsequently SB, the literature indicates that up to 17% of LBW and consequently 26% of SB
could potentially be prevented by changing position to avoid back sleep. Note that 20 million
LBW and 2.6 million SB occur each year worldwide.
Positional therapy (PT) is a safe and effective intervention for preventing people who snore
or people who's breathing pauses during sleep from sleeping on their back - a position that
makes their condition worse. The most basic form of PT modifies a person's sleeping position
by either:
- Preventing them from sleeping on their back through restricting their movement, or
- Rather than restricting movement, significantly reducing the amount of time they spend
sleeping on their back by applying pressure points to their body while they are on their
back, which eventually causes them to shift into a different position and avoid lying on
their back.
The purpose of this study is to evaluate the ability of a PT intervention to modify the
position of pregnant women from their back and right side to their left side while they sleep
in late pregnancy.
This study will help determine whether this potential risk factor is modifiable by way of a
PT intervention, and whether it is feasible to intervene to reduce or prevent back and
right-sided position sleep in late pregnancy. Demonstrating that the sleeping position of
pregnant women can be modified through use of a simple, inexpensive PT intervention may be
one of the keys to achieving significant reductions in LBW and late SB rates in Canada and
worldwide.
The utility of the PrenaBelt in modifying maternal sleeping position and the effect of the
PrenaBelt on maternal respiratory and cardiovascular parameters during sleep and sleep
staging in the third trimester of pregnancy will be evaluated via a two-night, randomized,
cross-over, sham-controlled, triple-blind, sleep study in third trimester pregnant women.
Two nights: one night with a positional therapy (PT) device and one night with sham-PT device
to determine treatment effect on outcomes.
Randomized: participants will be randomized to treatment order: sham-PT on first night, then
PT on second night, or vice versa. This will avoid the potential impact of changes to sleep
across the two nights resulting from familiarization with the equipment, which could bias the
results.
Cross-over: on the second night, each participant will be crossed over from PT to sham-PT (or
vice versa, depending on randomization order) to allow each participant to act as her own
control for comparison of treatment effect on outcomes.
Sham-controlled: a sham-PT device that has the same fit and form of the PT device but without
the ability of function (pressure points) will be used as a control. The purpose of a sham-PT
device is to identify any specific benefit of one element of a PT device (e.g., fit or form)
above and beyond all benefits that might be attributed to everything else about that device
(e.g., function). Note that there is no established effective therapy for the population for
the indication under study.
Triple blind: participants, sleep technologists monitoring and scoring the sleep tests, and
the specialized sleep physician reviewing and reporting the sleep test results will be
blinded to the intervention received each night.
Laboratory: conducting this study in a controlled lab setting will allow for continual, real
time monitoring of various cardiovascular, respiratory, and sleep parameters of each
participant by the sleep technologist. This contributes to a more controlled and safer study
overall.
Sleep test: body position, various cardiovascular and respiratory parameters, and sleep
parameters will be continuously recorded while the participants are sleeping. Sleep lab
procedures will be followed by the personnel conducting, scoring, reviewing, and reporting
the sleep tests from participant preparation through discharge
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Completed |
NCT02408315 -
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
|
Phase 3 |